Sara Elford - Net Worth and Insider Trading
Sara Elford Net Worth
The estimated net worth of Sara Elford is at least $157,215 dollars as of 2024-11-13. Sara Elford is the Director of Biosyent Inc and owns about 14,100 shares of Biosyent Inc (TSXV:RX) stock worth over $157,215. Details can be seen in Sara Elford's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sara Elford has not made any transactions after 2019-06-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sara Elford
Sara Elford Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sara Elford owns 1 companies in total, including Biosyent Inc (TSXV:RX) .
Click here to see the complete history of Sara Elford’s form 4 insider trades.
Insider Ownership Summary of Sara Elford
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TSXV:RX | Biosyent Inc | 2019-06-24 | Director |
Sara Elford Latest Holdings Summary
Sara Elford currently owns a total of 1 stock. Sara Elford owns 14,100 shares of Biosyent Inc (TSXV:RX) as of June 24, 2019, with a value of $157,215.
Latest Holdings of Sara Elford
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TSXV:RX | Biosyent Inc | 2019-06-24 | 14,100 | 11.15 | 157,215 |
Holding Weightings of Sara Elford
Sara Elford Form 4 Trading Tracker
According to the SEC Form 4 filings, Sara Elford has made a total of 0 transactions in Biosyent Inc (TSXV:RX) over the past 5 years. The most-recent trade in Biosyent Inc is the acquisition of 300 shares on June 24, 2019, which cost Sara Elford around $1,980.
Insider Trading History of Sara Elford
- 1
Sara Elford Trading Performance
GuruFocus tracks the stock performance after each of Sara Elford's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sara Elford is -10.67%. GuruFocus also compares Sara Elford's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sara Elford within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sara Elford's insider trading performs compared to the benchmark.
Sara Elford Ownership Network
Ownership Network List of Sara Elford
Ownership Network Relation of Sara Elford
Sara Elford Owned Company Details
What does Biosyent Inc do?
Who are the key executives at Biosyent Inc?
Sara Elford is the Director of Biosyent Inc. Other key executives at Biosyent Inc include Senior Officer Sharan Raghubir , 10% Security Holder & Director & Senior Officer Rene Goehrum , and Issuer BioSyent Inc. .
Biosyent Inc (TSXV:RX) Insider Trades Summary
Over the past 18 months, Sara Elford made no insider transaction in Biosyent Inc (TSXV:RX). Other recent insider transactions involving Biosyent Inc (TSXV:RX) include a net sale of 6,304 shares made by Seyed Ahmad Ashrafi , a net sale of 5,505 shares made by Sharan Raghubir , and a net sale of 1,235 shares made by Peter Douglas Lockhard .
In summary, during the past 3 months, insiders sold 5,939 shares of Biosyent Inc (TSXV:RX) in total and bought 0 shares, with a net sale of 5,939 shares. During the past 18 months, 14,566 shares of Biosyent Inc (TSXV:RX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,566 shares.
Biosyent Inc (TSXV:RX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biosyent Inc Insider Transactions
Sara Elford Mailing Address
Above is the net worth, insider trading, and ownership report for Sara Elford. Currently GuruFocus does not have mailing address information for Sara Elford.